Prostate Cancer and Androgenic Alopecia

The document from 2012 examines the potential connection between androgenic alopecia (AA) and prostate cancer (PC), both of which are common in older men and influenced by androgens, particularly dihydrotestosterone (DHT). While studies have produced inconsistent results regarding the association between AA and PC, the document highlights the use of finasteride, a medication that treats AA and may reduce the incidence of PC. It also mentions a hypothesis that AA could be protective against PC due to increased UV exposure and vitamin D production in balding individuals. A rare genetic variant (SRD5A2 A49T) is noted to be associated with a lower risk of AA and a higher risk of PC, although it is not prevalent in the general population. The document concludes with a call for more research, including genomic studies and analysis of the scalp and prostate microenvironments, to better understand the link between these conditions and potentially improve screening and treatment strategies.